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Background: Mobile applications (apps) have proven to be useful in supporting diabetes
self-care, but non-consideration of users’ needs and non-inclusion of educational features are
reasons for low continual use. Well-designed mobile apps that meet the needs of diabetes
patients and provide ongoing self-management education and support are required. It was
hypothesized that apps designed with such features can improve a range of measures
including clinical outcomes, knowledge of diabetes, medication adherence, perceived ability
for self-management, and quality-of-life. This may eventually facilitate a more robust and
cost-effective approach for improving skills and motivation for the management of diabetes.
Methods: This project will be conducted in two phases. It will initially employ a mixed
methods study design to investigate the self-management needs and perceptions of diabetes
patients on the use of mobile apps to support diabetes self-management. Results of the mixed
methods study will inform the content and design of an app which will be employed as an
intervention tool in a 12-month parallel randomized controlled trial (RCT). The RCT will
compare outcomes in relation to standard-of-care alone with standard-of-care plus a mobile
phone diabetes app among 150 insulin-requiring types 1 and 2 diabetes patients. The primary
outcome measures are clinical parameters such as hemoglobin A1c (HbA1c), lipids, urine
albumin-to-creatinine ratio, blood pressure, frequency in events of emergency hyperglycemia
and hypoglycemia. Secondary outcomes include knowledge of diabetes, medication intake
and adherence, perception of self-care, and quality-of-life.
Discussion: Results from this study will provide empirical evidence on the usefulness of
a mobile app developed based on self-management needs analysis of diabetic patients. The
long-term goal is to harness knowledge gained from this study to provide evidenced-based
data, which promote the scale-up or adoption of mobile applications that provide regular,
ongoing education and self-management support to people living with diabetes.
Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12618000065291,
Registered on 17 January, 2018 (prospectively registered).
Keywords: randomized controlled trial, mixed methods design, diabetes, self-management
education, mobile application
Introduction
Developing knowledge and skills on targeted self-management behaviors for the
prevention and early detection of diabetes complications can only occur through
a process of learning known as Diabetes Self Care Education (DSCE).1,2 DSCE
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should go beyond the present recommendation of occur-
rence at diagnosis, annually, when a new complication sets
in or during transition in care,3,4 to a more regular event
with consistent reinforcement of educational components.5
This is essential to promote awareness of the importance
of self-management, build the resilience needed to over-
come barriers, cope with ongoing demands, and sustain
required behaviors during the course of treatment and life
transitions.6,7 Studies have shown better clinical outcomes
in patients with every increment in time spent on diabetes
education.8–10
In most cases, the complexity, chronic nature of dia-
betes, and the required daily management usually make
adherence to prescribed self-management recommendations
difficult for patients.11,12 Poor adherence usually results
from the fact that a significant percentage of patients do
not have sufficient knowledge, skills, motivation, and self-
efficacy for self-management, which consequently results in
complications.13,14 Insight into specific self-management
areas where people with diabetes are often lacking in under-
standing, skills, motivation, and efficacy can inform the
planning of an improved educational intervention.
With advancement in computer programming and ubi-
quity of mobile communication devices, it is possible to
leverage on these technologies to empower patients
through regular self-monitoring and disease management
programs.15 Technologies in the form of websites, soft-
ware applications, and mobile devices have persuasive
attributes that can change users’ attitudes or behaviors in
a predetermined way.16,17 The use of these technologies
enables the delivery of healthcare outside the clinical
environment,18 and provides ongoing self-management
support and education.19,20 These technologies foster
improved knowledge and promote the importance of
daily self-management activities to prevent the risk of
complications in patients with diabetes.21–24 However,
despite the several advantages, proven effectiveness, and
investments into the technological development process of
apps for diabetes self-management; two major issues have
limited the successful adoption of apps as a self-
management tool. First, previous use of apps as interven-
tions was characterized by high attrition rates.25–29 This
low level of continuous acceptance has been attributed to
insufficient consideration of users’ perceptions of its
usability requirements.30–32 Second, self-management edu-
cation, which is a critical component of diabetes care, has
been shown to be an under-represented feature in the
majority of available diabetes mobile apps.19,33–35
The reported body of evidence on significant deficits in
patients’ knowledge, skills, and efficacy for diabetes self-
management suggests the necessity for a participatory eva-
luation of the self-management education needs of patients.
The needs analysis will provide insight into specific areas of
reinforcement during diabetes education intervention.
Additionally, high attrition rate serves as a limiting factor
in the ongoing use of apps as a self-management tool. This
problem is an indication of the importance of assessing the
mobile app needs of patients in terms of preferred app
features and exploring their recommendations on how to
foster better engagement with diabetes self-management
apps. Although there are many currently available diabetes
self-management apps, the majority of them were not devel-
oped with users’ input, neither do they lead to long-term
improved health and behavioral outcomes.36 Developing
a diabetes app that best meets identified patients’ needs
with the inclusion of consistent educational features could
possibly provide an effective method to increase patients’
knowledge, skills, efficacy, motivation, and compliance with
recommended self-management activities. Ultimately, this
procedure may improve health outcomes, quality-of-life,
and prevent or delay the onset of diabetes complications.
Therefore, the study aims to:
1. Assess the needs of patients with regards to their
self-management skills and efficacy, preferred fea-
tures in apps, and opinions on better engagement
with mobile apps for diabetes management;
2. Develop a mobile app that best meets patients’
identified needs;
3. Use a randomized controlled trial to investigate the
impact of the developed mobile app on hemoglobin
A1c (HbA1c), albumin creatinine ratio (ACR), blood
pressure (BP), lipids, anthropometric parameters, and
events of hypoglycemia and hyperglycemia;
4. Estimate changes in knowledge of diabetes manage-
ment, medication intake and adherence, perceived
efficacy in diabetes self-management, and quality-of-
life pre- and post-intervention; and
5. Determine the cost-effectiveness of the intervention
relative to standard care.
Study hypothesis
The use of a mobile app developed based on self-management
education and support needs of people with diabetes will
improve clinical outcomes, diabetes management knowledge,
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medication adherence, perceived ability to perform self-
management, and quality-of-life.
Significance and innovation of research
Based on the proposed hypothesis, this project is expected to
provide better health outcomes for people with diabetes
through excellent and innovative provision of self-support
and educational intervention. The educational delivery
model is intended to utilize best practice educational meth-
ods and persuasive technologies to maximize improved
health outcomes. The strength of this research lies in its
targeted approach at meeting priority patient needs, connec-
tive links to health education, and fostering better health
outcomes and quality-of-life for people with diabetes.
The results of this study will promote diabetes patients’
self-management via consistent and effective education and
support in order to reduce their risk of developing complica-
tions. Furthermore, it is hoped that the outcome of this project
will contribute to meeting one of the goals of the Australian
National Diabetes Strategy 2016–2020, which is to “reduce
the occurrence of diabetes-related complications and improve
the quality-of-life among people with diabetes”.37
Research plans and methods
Figure 1 shows a detailed outline of the research plan. The
project will be conducted in two phases using a mixed
methods study design and randomized controlled trial,
respectively.
Phase 1
Study design and population
This phase will utilize a mixed methods study design to
identify the common self-management education needs
and perceptions of the use of mobile apps for self-
support among people who have diabetes. This method
allows for a complete and synergistic utilization of data
to validate findings from qualitative and quantitative data
sources.38Any person with type 1 or type 2 diabetes and
above the age of 18 years is eligible to participate in this
study. This study is cross-sectional in nature and mainly
Mobile phone application study
Phase 1: Mixed Methods Study Design
Mobile app development
Phase 2: Randomized controlled trial
Obtain consent
Randomized
Usual care (n=75) Usual care + intervention 
(n=75)
Baseline HbA1c, Lipids, BP, ACR 
HbA1c, Lipids, BP, ACR 
Knowledge of diabetes, medication adherence, perception on ability 
for self-care and quality of life
Baseline characteristics, 
Knowledge of diabetes, 
medication adherence, 
perception on ability 
for self-management
and quality of life
0-1 month
4,8,12 months
12 months
Figure 1 Detailed outline of research plan
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aims at estimating the frequency of health behaviors and
consensus on features in a mobile health technology.
A priori statistical G-power analysis39 was conducted to
estimate the minimum sample size required to reduce the
risk of Type 1 and Type 2 errors. The analysis revealed
that 128 participants are required to achieve 80% power
with level of significance set at a standard of 5% in order
to control for type 1 error.
Data collection
Data will be collected via online survey (designed using
Survey Monkey) and individual telephone interviews. The
study will be advertised widely and internationally through
social media outlets, websites of diverse diabetes associa-
tions, and local newspapers. Advertisement will ensure
that various demographics and international audiences
are adequately represented. Participants will complete a -
10–12 minute online questionnaire sub-divided into three
major parts: i) demographic characteristics; ii) validated
tool for assessing self-management education, skills, and
self-efficacy needs;40 iii) questions developed from
a review of published literature to elucidate patients’ pre-
ferred features in diabetes management apps and recom-
mendations to foster better engagement with such apps.
The main content of the questionnaire will follow an
information and consent page.
Upon completion of the questionnaire, participants will
be invited to participate in a 10–20 minutes telephone
interview. Consenting participants to this part of the
study will be asked to provide their preferred phone con-
tact details. The interview session will provide an oppor-
tunity for data triangulation and in-depth understanding of
the findings from the survey. The interview process will be
ongoing until data saturation is attained enabling the
research questions to be adequately answered. Data satura-
tion is reached when incoming information results in mini-
mal or no changes to the codebook.41
Quantitative data analysis
Data from the questionnaire will be summarized using
descriptive statistics. Demographic predictors of self-
management skills and efficacy as well as perceptions of
preferred app features will be identified using bivariate and
regression analyses.42 Significance levels will be set at
a P-value less than 0.05.
Qualitative data analysis
Data from telephone interviews will be audiotaped, tran-
scribed, and analyzed in N-Vivo using in-depth thematic
analysis for identifying, analyzing, reporting patterns
within the data, organizing (minimally) and describing
the data in rich detail.43 The data will be subjected to
inductive, bottom-up analysis to elicit emerging themes
that are directly linked to the study.43
Outcomes
The major outcomes of interest for this phase of the study
include common self-management education needs of
patients identified through knowledge gaps in specific
diabetes management skills and self-efficacy; preferred
features in mobile diabetes app and approaches to foster
consistent engagement with self-management diabetes
apps. These findings will inform the development of
a new mobile app and self-management educational inter-
vention. This phase is geared towards achieving the first
and second aims of the project.
Development, usability and pilot testing
of mobile app
We hypothesized that participants’ preferences will be influ-
enced by their educational status, age, country of residence,
level of familiarity with modern technologies, and the type of
diabetes they have. Therefore, the results emanating from
this phase of the project will be thoughtfully considered and
prioritized in the development of the app. Priority will be
given to nominated app features with empirical evidence on
the management of diabetes and best interventional techni-
ques likely to promote health behavioral change. Features
and ideas that maximize usability and engagement with the
app will also be considered. Overall, the app will be designed
based on the identified needs of the users.
The newly-developed mobile app will be validated in
two stages. In the first stage, usability testing of the user
interface, app design elements, and satisfaction with the
app will be done using an adapted version of the Mobile
App Rating Scale (MARS).44 MARS is a useful tool
which could provide essential information for the design
and development of new apps in terms of assessing an
apps’ esthetics, functionality, and information quality. The
tool has been found to be simple, objective, and reliable
for assessing the quality of a broad spectrum of user
interfaces.44 A mix of participants including a minimum
of 10 members of the public and people who have type 1
or type 2 diabetes will be asked to use the app and provide
feedback using the adapted tool. This strategy is essential
for ascertaining the technical performance of the app and
navigation issues (if any) when downloaded on various
Adu et al Dovepress
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mobile phones. Necessary improvement to the app will be
made according to results from the usability testing. The
second stage will involve pilot testing of the app in order
to assess its’ acceptability and feasibility and preliminary
efficacy for wider implementation in the randomized con-
trolled trial.
Phase 2
Study design
This phase will be a parallel randomized controlled trial
(RCT) comparing patient outcomes for standard-of-care
alone vs standard-of-care plus a mobile diabetes app inter-
vention (newly-developed app). RCT allows for rigorous
research to determine cause–effect relationships between
intervention and outcomes and ensure that there are no
systemic differences between both groups that may affect
results.45
Setting
The research will be conducted in the diabetes centers of
a tertiary hospital and a community health campus in
North Queensland, Australia. Both centers are operated
by the Townsville Hospital and Health Service. This ser-
vice serves a socially and ethnically diverse group of
people with diabetes.46
Most public hospital services in Australia are financed by
the state, territory, and the Australian Commonwealth
Governments. Australia’s health funding, referred to as
Medicare, largely covers the necessary healthcare cost that
patients require, including medical services, allied health
services, and pharmaceuticals.47 In addition to Medicare,
the National Diabetes Service Scheme (NDSS) provides
a range of support services to Australians diagnosed with
diabetes. Part of the services includes payment for accessing
diabetes self-management education (DSME) from
a Credentialed Diabetes Educator. The focus of DSME is
the provision of support which may be educational, psycho-
social, or clinically guided by evidence-based standards.48,49
Eligibility
Eligibility criteria include i) Adults above 18 years of age;
ii) Diagnosed with type 1 or 2 diabetes; iii) Using insulin
therapy with or without oral antidiabetic agents; iv) Using
a smart phone; and v) Willing to return for follow-up at 4,
8, and 12 months. Inclusion of only insulin-requiring type
1 and type 2 diabetes patients was based on the fact that
diabetes patients with these characteristics have the high-
est likelihood to regularly monitor their blood glucose
levels, since it is a standard pre-requisite prior to insulin
dose administration. Additionally, there is a high probabil-
ity that the new app will include a blood glucose tracking
feature because regular blood glucose monitoring is an
important self-management activity for diabetes patients
(especially those requiring insulin administration as part of
their treatment regimen). Inclusion of type 2 diabetes
patients who do not use insulin will be an additional
burden to their self-management, since such patients will
have to regularly monitor their blood glucose in order to
use the blood glucose tracking feature of the app. Studies
have reported reduced acceptability and engagement with
health technologies that are perceived by patients to be
burdensome.50
Type 1 and 2 diabetes patients with major diabetes
complications (such as kidney failure and lower limb ampu-
tation), pregnancy, and psychiatric co-morbidity will not be
eligible to participate in the study. This exclusion is based
on the fact that this set of medical conditions requires close
medical monitoring and unique self-management needs,
which the intervention is not likely to address.
Recruitment
A trial nurse will screen for eligible potential participants.
The nurse will work in collaboration with the booking
officer to obtain patients’ mailing addresses. A detailed
information sheet explaining the goal and conduct of the
study will be mailed to eligible participants 2 weeks ahead
of their clinic appointments. This is to give them prior
information about the study and allow eligible participants
ample time to make a decision on whether they wish to
participate or not. The email address and phone number of
the principal investigator will also be provided in the event
that prospective participants require some clarification
about the study. Initial contact will be on the clinic day
when the principal investigator describes the study and
offers participants time to ask any study-related questions.
Participants interested in the study will then be presented
with the informed consent form to sign.
Allocation, blinding, and orientation
The principal investigator will assign enrolled participants
study numbers to aid de-identification, and the numbers
will be used for random allocation into one of the groups
using optimal multivariate matching.51 Participants will be
matched based on HbA1c, type of diabetes, and duration
of diagnosis. Those in the control group will continue with
their standard care, while those in the experimental group
Dovepress Adu et al
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will receive the intervention in addition to their regular
care. Blinding of participants is not possible due to the
nature of intervention involved. However, initial contact
and orientation (on app use) for intervention participants
will take place on aone-on-one basis. Therefore, partici-
pants may not be aware of others in similar or different
groups. Technical support for app use will be offered to
those in the intervention group by giving them a phone call
at least twice during the first 2 months of the study.
Intervention
Intervention will entail the use of the newly-developed
mobile phone app, which focuses on self-management
education and support, for 12 months.
Mobile application
The mobile app will contain essential diabetes management
features for tracking blood glucose, physical exercise, diet,
in addition to other preferred features that may be identified
from the mixed methods study. Furthermore, the app will
have personalized educational features that provide com-
puted algorithm feedback messages in response to reported
blood glucose measurements. Several separate feedback
messages will be developed and input into the app to be
controlled by a decision-based system. Rules will be set,
stipulating requirements for messages to be delivered to
patients. These requirements will be specific to the indicated
type of diabetes, value of blood glucose (whether within or
beyond the standard recommended range), and the period of
blood glucose measurement (either fasting or 2 hours post-
prandial). In addition, regular randomization to guard
against unnecessary repetition of the same message will
be integrated into the decision-based system. These mes-
sages are evidence-based, motivational, health promotional,
and behavioral skills information aimed at supporting self-
management practices. For example, where a type 1 DM
participant logged a fasting BG of 6 mmol/L, feedback
message may include “Excellent: BG appears within recom-
mended target range, continue your medication as pre-
scribed“, or “Excellent . . . keeping BG levels within target
range reduces the risk of complications”. In situations
where the inputted BG value is in the range of emergency
hyperglycemia (≥14 mmol/L) consistently, an immediate
contact with the patient’s health provider will be recom-
mended. The intervention group will be instructed to log
their blood glucose measurements into the app twice weekly
at a minimum. Data logged into the app will be automati-
cally transferred to a secured, password protected cloud
storage accessible by the principal investigator only.
Participants will be informed about the automatic transfer
of the logged data into a cloud storage and consent will be
obtained to access the information.
Given that the app will be used by both type 1 and type
2 diabetes patients who have different care guidelines with
regards to recommended blood glucose values, it is impor-
tant to ensure that the app is suitable for both groups of
patients. Furthermore, although recommendations for diet,
exercise, and associated education are different for both
groups of patients, they have the common characteristic of
developing hypoglycemia when exercise, food, and insulin
are not balanced. Hence, we aim to provide educational
messages in the app that include information on strategies
to balance exercise (especially long duration) and diet with
blood glucose levels and insulin.
Self-management education
Through the mobile app, general messages will be pro-
vided, in addition to personalized automated messages.
Messages will reinforce information on the seven essential
diabetes self-management behaviors that predict good out-
comes, namely: lifestyle modifications (healthy eating and
improved physical activity), monitoring of blood sugar,
complying with medications, good problem-solving skills,
healthy coping skills, and risk-reduction behaviors (such
as smoking cessation and reduction in alcohol intake).7
Essentially, there will be emphasis on the indicated com-
mon educational needs for self-management deduced from
the results of the mixed methods study. Educational infor-
mation will be prepared by MDA, who is a diabetes edu-
cator, based on guidance and advice from UM, who is an
Endocrinologist. The frequency of delivery of general
education via the app will be twice a week. Conciseness
and simple formatting of messages will be ensured so that
the provided education can benefit all participants, regard-
less of literacy level.
Standard care
Participants in the control group will receive standard care
only. Standard care for diabetes in Australian Hospitals
comprises consultation with a physician diabetes specialist
at 3–4 month intervals. During this period, depending on
individual healthcare needs, patients will be managed in
a collaborative care arrangement between the specialist
and other allied health professionals such as diabetes edu-
cators. The key areas of education include, but are not
limited to, healthy eating, physical activity, reducing the
Adu et al Dovepress
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risk of complications, monitoring blood glucose, and using
results to improve diabetes management.52
Data collection at different time points
Pre-intervention
After initial contact and enrolment, patients will complete
a questionnaire about their baseline information on socio-
demographics, medical, and family history of disease. The
questionnaire was developed for the study based on
a review of published literature.
Additionally, information on diabetes management
knowledge, medication adherence, perceived ability for
self-management, and quality-of-life will be elucidated
using self-administered validated questionnaires. Please
see Table 1 for an outline of the validated questionnaires.
Baseline, 4, 8, and 12 months during intervention
The primary outcomes of interest are the clinical data
which will be assessed at four different time points (intake,
4, 8, and 12 months). Relevant clinical outcomes include
HbA1c, BP, lipids, ACR, weight, height, waist circumfer-
ence, events of emergency hypoglycemia, and hyperglyce-
mia. These parameters are requested by the patient’s
doctor as part of routine care, hence there will be retro-
spective collection of these measures from each partici-
pant’s hospital record at each data collection time point. At
the time of enrolment, patients will be asked to provide
consent to retrieve these data from their clinical records.
Post-intervention
At the end of 12 months, intervention will stop and all parti-
cipants will be invited to a final visit to enable them to fill out
the post-intervention questionnaires to assess the secondary
outcomes. These will be the same validated questionnaires
administered at the start of the pre-intervention study.
Additionally, at this final visit, a questionnaire devel-
oped for the study will be used to assess participants’ level
of acceptability of the app. The questionnaire will consist
of items pertaining to satisfaction, usability, functionality,
and willingness to use the app in the future and/or recom-
mend to other patients.
Furthermore, data on direct and indirect healthcare
costs will be collated to determine the cost-effectiveness
of the intervention. Direct costs of implementing the inter-
vention are costs associated with personnel, operating,
maintenance, utilities, and capital. Hospital visit costs
due to emergency complications (if any) as well as pre-
dicted long-term healthcare costs incurred in relation to
chronic complication development (if any), will also be
determined. Indirect health costs will entail transportation
to clinic appointments due to emergency complications
and loss of productivity from being absent from work or
usual activity due to such complications. Cost of standard
care will also be factored in.
App utilization will be tracked directly from the num-
ber of data logged into the app and extracted from cloud
storage at the end of the study.
Sample size calculation
A priori statistical power analysis was computed using
G-power.39 Estimation of sample size was done using
expected change in HbA1c as the primary outcome. A 0.4%
reduction in HbA1c level in the intervention group was
expected with a statistical criterion level of 0.05 (two-tailed).
This analysis also indicated that 68 participants per control and
intervention group will be required to achieve 80% power for
detecting differences in the outcomes of interest between both
groups. The total sample size was increased to 150 to allow for
drop out, which is peculiar to longitudinal studies.53 The
Table 1 Measures of secondary outcomes
Outcomes Measures Description of measures
Knowledge of diabetes Revised Michigan Diabetes
Knowledge Scale68
Knowledge of monitoring blood glucose, diet, exercise, and other self-activities.
In a previous study,69 the tool’s subscales obtained a Cronbach’s alpha of >0.80.
Ability for self-care Diabetes Self-Management
Questionnaire70
Four subscales that assess perception on ability on dietary control, glucose
management, physical activity, and healthcare use. The subscales of the tool have
a good internal consistency (0.84).70
Adherence to prescribed
medication
Medication Adherence Scale71 Patient’s medication-taking behavior. The subscales of the tool have an alpha
reliability of 0.61.68
Quality-of-life Quality-of-Life (AQoL-8D)
questionnaire72
Physical, Social, Mental dimensions of health, in addition to health utility index and
quality of wellbeing. The subscales of the tool have a good internal consistency
(0.96).72
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chosen effect size, significance level, and statistical power
were derived from inspecting previous similar trials.54,55
Statistical analysis
Analysis of this RCT will be performed by intent-to-treat
(ITT) principle, including all randomized participants.56
Primary outcome variables (clinical parameters) will be
analyzed as continuous variables and dichotomized.
Randomization is expected to produce similar groups;
therefore, baseline demographics and clinical variables
will be compared using two sample t-tests for continuous
variables and chi-square test or Analysis of Variance
(ANOVA) for categorical variables. Furthermore, adjusted
group comparisons using multilinear and logistic regres-
sions will be carried out. Covariates will include clinically
relevant baseline characteristics such as age, duration of
diagnosis, HbA1c, and co-morbidities.
To determine the effect of the intervention on clinical
parameters, Bonferroni pair-wise comparison tests for
multivariate analysis and/or mixed effects regression mod-
eling will be used to compare mean changes between the
two groups. The extent to which improvement in clinical
parameters mediate reduction in complication develop-
ment will be assessed by fitting two linear/logistic regres-
sion models, one including only group characteristics
(such as age, sex, baseline HbA1c level) and the other
incorporating both group effect and the intervention as
covariates. The degree to which group characteristics are
abated after adding the intervention into the model pro-
vides an indication of the mediating effect.57
Secondary outcomes will be reported using descriptive
statistics. Any statistically significant difference in these
outcomes (pre- and post-intervention) between the inter-
vention and control groups will be assessed using appro-
priate parametric and non-parametric statistics.
Economic evaluation will entail the cost-effectiveness and
cost of implementing the intervention. Cost-effectiveness will
be expressed as an Incremental Cost-Effectiveness Ratio
(ICER),58 while direct and indirect costs will be computed to
determine the cost consequences of the intervention.
Data on app utilization and acceptability will be analyzed
descriptively. All statistical analyses for this phase of the study
will be performed using SPSS software and a P-value<0.05
will be considered to be statistically significant.
Study approval and consent to participate
The Phase 1 study procedure received approval from the
James Cook University Human Research Ethics Committee
(Permit number H707). The Phase 2 (RCT) protocol was
approved by the Human Research Ethics Committee of the
Townsville Hospital and Health Service (Permit Number
HREC/17/QTHS/148). Electronic and audio consents will
be obtained from participants in phase 1 as deemed appro-
priate. All participants for phase 2 will be required to
provide written informed consent. The trial has been regis-
tered on Australian New Zealand Clinical Trials Registry,
ACTRN12618000065291.
Data storage/confidentiality
All data from this study will be stored in accordance with
the Australian Code for the Responsible Conduct of
Research.59 All data will be treated as confidential. Any
data stored on an electronic device will be de-identified.
All completed questionnaires and consent forms will be
securely stored in a locked file cabinet. Only members of
the research team will have access to the final data set.
Dissemination of research findings
The knowledge gained from this study will be dissemi-
nated through publications in peer reviewed journals and
presentations at academic conferences.
Time frame for the study
At the time of submission of this manuscript, data collec-
tion for Phase 1 (mixed methods study) had been com-
pleted with 217 and 16 participants in the survey and
telephone interviews, respectively. The results of the ana-
lysis will inform the content and design of the intervention
app. The app will be developed with the assistance of
software developers who will work in collaboration with
the authors of this study. As at the submission of this work
for publication, several meetings have been held between
the authors and the software developers on the app devel-
opment. It is anticipated that the mobile app design,
usability, and pilot testing will be completed in 2019,
and the randomized control trial of its efficacy will com-
mence in 2020.
Discussion
The strength of this research lies in the use of mixed methods
study design to seek information from a multinational audi-
ence (Phase1) in order to address knowledge gaps in patients’
preferences for apps features as well as their self-
management skills and efficacy, and perceptions on how to
foster better engagement with diabetes self-management
mobile apps. This approach is hypothesized to increase the
opportunity for maximizing patients’ engagement with the
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app because it emphasizes shared decision-making and
ensures input from end-users.60,61
The objective of the international study is to identify
global patient preferences for essential features in diabetes
apps, common gaps in skills and self-efficacy for diabetes
management, and recommendations on motivators to foster
long-term engagement with apps. We believe these objec-
tives will be relevant in any app development because,
regardless of location/setting, recommended standard of
care and therapeutic management of diabetes is regulated.
Nevertheless, in the event that results from phase 1 reveal
the need for country-specific requirements for app features
and functionalities, such information will be utilized in the
development of an app that is adequate and suitable for use
in an Australian context. The intervention will be designed
to use mobile app technology and provide self-management
and educational support to Australians who have insulin-
requiring type 1 or type 2 diabetes.
Mobile apps have the potential to motivate and support
healthy lifestyle decisions in patients with chronic dis-
eases, such as diabetes.62–64Additionally, mobile apps can
be used to provide regular diabetes self-management
information.65,66 Availability of the support and education
on an ongoing basis will enable improved management
and reduced morbidity and mortality.9,67 Results from
these studies will provide the much-needed information
on patients’ self-management education needs, their pre-
ferred app features, and opinions on how to foster engage-
ment with diabetes apps in order to improve health
outcomes for diabetes patients. The benefits expected
from the studies include:
● Identification of the needs of patients with regards to
self-management skills and efficacy, preferred fea-
tures in apps, and opinions on better engagement
with a mobile app for diabetes management;
● Promotion of diabetes self-management;
● Improvement of clinical outcomes, knowledge, self-
care abilities, medication adherence, and quality-of-life;
● Reduction of the huge burden of diabetes on the
healthcare system; and
● Meeting one of the goals of the Australian National
Diabetes Strategy 2016–2020 to reduce the occur-
rence of diabetes-related complications and improve
the quality-of-life among people with diabetes.
Limitations of this project include the use of self-reported
measures in Phase 1 and secondary outcomes for Phase 2.
Compared to objective measures, self-reported measures are
liable to recall bias and social desirability. Nevertheless, self-
reported measures are brief and less expensive to administer.
Additionally, we aim to use validated tools to strengthen the
study. Another limitation is that, because the RCT is powered
to examine the effectiveness of the mobile app on HbA1c,
therefore, analysis examining the effect of the secondary out-
comesmay be underpowered. However, this does not deter the
results of the outcomes from being informative.
Overall, we anticipate that this research project will be
able to meet priority patient needs, have connective links
to health education, and foster better health outcomes and
quality-of-life for people with diabetes.
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